Dramatic response to nebulized morphine in an asthmatic patient with severe chronic cough

Irish Medical Journal

Volumn 95, Issue 4, 2002, Pages 113-114

  Rutherford, R M ^a   Azher, T ^a   Gilmartin, J J ^a  

^a Merlin Park University Hospital   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; BUDESONIDE; FLUTICASONE; IPRATROPIUM BROMIDE; LIDOCAINE; MORPHINE SULFATE; NEDOCROMIL SODIUM; PREDNISOLONE; TERBUTALINE; ZAFIRLUKAST;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CHRONIC DISEASE; COUGHING; DISEASE SEVERITY; EXERCISE TOLERANCE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; MALE; NEBULIZER; QUALITY OF LIFE; SIDE EFFECT; SOCIAL PROBLEM; TREATMENT FAILURE; TREATMENT OUTCOME; UNEMPLOYMENT; VITAL CAPACITY;

ASTHMA; CHRONIC DISEASE; COUGH; HUMANS; MALE; MIDDLE AGED; MORPHINE; SPIROMETRY;

EID: 0036277476     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. The clinical efficacy and cost benefits of inhaled corticosteroids as therapy in patients with mild asthma in primary care practice
2. Lung function testing: Selection of reference values and interpretation strategies
3. The effects of drugs on cough
4. Palliation of respiratory symptoms
5. Lung opiate receptors: Pharmacology and possible target for nebulized morphine in dyspnoea
6. Effect of inhaled and systemic opiates on responses to inhaled capsaicin in humans
7. Systemic absorption of nebulized morphine compared with oral morphine in healthy subjects